Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventionsStatus:Awaiting developmentProgramme:HealthTech guidanceExpected publication date: TBC
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and high lipoprotein (a) [ID6559]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Enlicitide decanoate for treating hyperlipidaemia in people at risk of an atherosclerotic cardiovascular disease event [ID6656]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [ID6733]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Point-of-care lipid tests for cardiovascular disease prevention in primary and community careStatus:Awaiting developmentProgramme:HealthTech guidanceExpected publication date: TBC